课题基金 / 基金详情

CELLULAR MECHANISMS OF CRACK COCAINES CARDIAC TOXICITY

CELLULAR MECHANISMS OF CRACK COCAINES CARDIAC TOXICITY
快克可卡因心脏毒性的细胞机制
批准号:
6174992
负责人:
JAMES P MORGAN
金额:
$18.92万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-05-15 至 2001-09-30

项目摘要

项目成果

JAMES P MORGAN的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Applicant's Abstract Cocaine and crack cocaine abuse have been reported to produce clinically significant cardiac depression, which in some patients may present as acute heart failure with cardiogenic pulmonary edema. Recent studies in our laboratory indicate that the negative inotropic actions of cocaine are mediated in part by muscarinic stimulation of the cardiac myocyte and may occur at low doses devoid of local anesthetic effect; methylecgonidine (MEG, the principle pyrolysis product of crack cocaine smoking) is more potent than cocaine as a muscarinic agonist on myocardium. The major goals of the proposed experiments are to delineate the cellular and molecular mechanisms that are affected by cocaine and MEG stimulation of cardiac muscarinic receptors, evaluate their functional significance with regard to contractile performance, and identify approaches to prevent or reverse their acute and subacute myocardial depressant effect in vivo. A variety of molecular and cellular techniques will be employed to identify the type(s) and subtype(s) of muscarinic receptors affected by cocaine versus MEG, which physiologic data indicate may differ, and to delineate specific cellular sites of action. The physiological significance of our findings will be tested in a model of ischemia that we predict will demonstrate the potential for these agents to exacerbate post ischemic cardiac dysfunction, or stunning. Experiments will be performed with ferret myocardium and transfected cell lines; however, we will demonstrate their relevance to man by confirmatory experiments with human myocytes. Taken together, these studies should enhance our understanding of the cellular mechanisms and functional significance of cocaine and MEG interaction with the cardiac muscarinic receptors and identify potential therapeutic approaches to the cardiac depression that can occur with abuse of these substances, even in patients with normal hearts.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Differential depressant effects of general anesthetics on the cardiovascular response to cocaine in mice.
全身麻醉药对小鼠可卡因心血管反应的不同抑制作用。
DOI: 10.1046/j.1525-1373.1999.d01-83.x
发表时间: 1999
期刊: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
影响因子: --
作者: [Wang,JF, Hampton,TG, Deangelis,J, Travers,K, Morgan,JP]
通讯作者: Morgan,JP
Metoprolol attenuates postischemic depressed myocardial function in papillary muscles isolated from normal and postinfarction rat hearts.
美托洛尔可减弱从正常和梗塞后大鼠心脏分离的乳头肌中缺血后抑制的心肌功能。
DOI: 10.1016/s0014-2999(01)01050-0
发表时间: 2001
期刊: European journal of pharmacology
影响因子: 5
作者: [Min,JY, Ding,B, Wang,JF, Sullivan,MF, Morgan,JP]
通讯作者: Morgan,JP
Mechanism of suppression of cardiac L-type Ca(2+) currents by the phospholipase A(2) inhibitor mepacrine.
磷脂酶 A(2) 抑制剂 mepacrine 抑制心脏 L 型 Ca(2) 电流的机制。
DOI: 10.1016/s0014-2999(00)00366-6
发表时间: 2000
期刊: European journal of pharmacology
影响因子: 5
作者: [Xiao,YF, Zeind,AJ, Kaushik,V, Perreault-Micale,CL, Morgan,JP]
通讯作者: Morgan,JP
Can cocaine abuse exacerbate the cardiac toxicity of human immunodeficiency virus?
滥用可卡因会加剧人类免疫缺陷病毒的心脏毒性吗?
DOI: 10.1002/clc.4960240302
发表时间: 2001
期刊: Clinical cardiology
影响因子: 2.7
作者: [Soodini,G, Morgan,JP]
通讯作者: Morgan,JP
7
    CORE--SMALL ANIMAL PHYSIOLOGY
    • 批准号:
      6589056
    • 项目类别:
    • 资助金额:
      $29.3万
    • 财政年份:
      2002
    • 负责人:
      JAMES P MORGAN
    • 依托单位:
    Core--Mouse physiology
    • 批准号:
      6584688
    • 项目类别:
    • 资助金额:
      $21.93万
    • 财政年份:
      2002
    • 负责人:
      JAMES P MORGAN
    • 依托单位:
    Core--Mouse physiology
    • 批准号:
      6557144
    • 项目类别:
    • 资助金额:
      $21.93万
    • 财政年份:
      2001
    • 负责人:
      JAMES P MORGAN
    • 依托单位:
    Core--Mouse physiology
    • 批准号:
      6445201
    • 项目类别:
    • 资助金额:
      $21.93万
    • 财政年份:
      2001
    • 负责人:
      JAMES P MORGAN
    • 依托单位: